Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nasdaq  >  Ophthotech Corp    OPHT   US6837451037

OPHTHOTECH CORP (OPHT)

7
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
The feature you requested does not exist. However, we suggest the following feature:

OPHTHOTECH : Submission of Matters to a Vote of Security Holders (form 8-K)

06/04/2015 | 04:09pm US/Eastern

Item 5.07 Submission of Matters to a Vote of Security Holders.

Ophthotech held its Annual Meeting of Stockholders on June 4, 2015. The following is a summary of the matters voted on at that meeting.

(a) Ophthotech's stockholders elected Axel Bolte and Samir C. Patel, M.D. as Class II directors to serve until the 2018 Annual Meeting of Stockholders, each such director to hold office until his successor has been duly elected and qualified. The results of the stockholders' vote with respect to the election of such Class II directors were as follows:



                                                Broker
                          For       Withheld   Non-Votes
Axel Bolte             27,661,897     46,328   3,148,234
Samir C. Patel, M.D.   27,103,760    604,465   3,148,234



(b) Ophthotech's stockholders ratified the selection of Ernst & Young LLP as Ophthotech's independent registered public accounting firm for the current fiscal year. The results of the stockholders' vote with respect to such ratification were as follows:



                                  Broker
   For       Against   Abstain   Non-Votes
30,686,411   163,570     6,478           0




                                       2

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses

React to this article
Latest news on OPHTHOTECH CORP
06/04 OPHTHOTECH : Submission of Matters to a Vote of Security Holders (form 8-K)
06/03 OPHTHOTECH : to Present at the Goldman Sachs 36th Annual Global Healthcare Confe..
05/20 OPHTHOTECH : Completes Patient Recruitment of the First Phase 3 Pivotal Trial of..
05/17 OPHTHOTECH : Patients Recruited for the 1st Phase 3 Pivotal Trial of Fovista Ant..
05/14 OPHTHOTECH : to Present at the Deutsche Bank 40th Annual Health Care Conference
05/14 OPHTHOTECH : Posts 1st Quarter 2015 Financial and Operating Results
05/14 OPHTHOTECH : Finalizes Recruits Patients for the 1st Phase 3 Pivotal Trial of Fo..
05/13 OPHTHOTECH : to Present at the UBS Global Healthcare Conference
05/11 OPHTHOTECH : beats Street 1Q forecasts
05/11 OPHTHOTECH : Reports First Quarter 2015 Financial and Operating Results
Advertisement
Chart
Duration : Period :
Ophthotech Corp Technical Analysis Chart | OPHT | US6837451037 | 4-Traders
Income Statement Evolution
More Financials